Mane·Lens

← Blog  ·  5 min read  ·  Product Analysis

How to tell whether a haircare trial actually means something

A study can be real, published, peer reviewed and still not support the sentence a brand has printed on the front of the bottle.

Clinically proven does a lot of work on a bottle and means almost nothing on its own. There is no regulated definition of it, and the gap between a real study and the claim built on top of it is where most haircare marketing lives.

You do not need a statistics background to close that gap. You need about five questions.

1. What was actually tested, and on what

This is the question that eliminates the most claims fastest.

A great deal of cosmetic research is done on tresses: bundles of hair mounted on a card, treated and measured. Tress work is genuinely useful. It is how combing force, tensile strength and surface chemistry get measured, and you cannot do those measurements on a person's head.

What it cannot tell you is what happens on a living scalp attached to a person with a routine, a climate and a styling habit. A tress does not have a follicle, sebum, a microbiome or a hairdresser.

Cell studies and animal studies sit further away again. A compound that upregulates a growth-associated gene in cultured dermal papilla cells has shown something real about that compound in that dish. The distance from there to hair appearing on a head is enormous, and it is routinely collapsed in marketing.

The ladder, roughly: Cell culture, then animal, then hair tresses, then human use studies, then randomised controlled trials in people. A claim about what a product does for a person needs evidence from the top of that ladder, not the bottom.

2. Compared with what

A result with no comparator is not a result. If everyone in a study used the product and 80% reported improvement, you have learned nothing, because you do not know what 80% would have reported using anything at all.

People in studies improve for reasons that have nothing to do with the active: they are paying more attention, handling their hair more gently because they are being observed, and answering questions they know the purpose of. A control group is what separates the product from the attention.

Randomisation decides who gets what by chance, so the groups start comparable. Blinding stops expectation shaping the answer, which matters enormously for subjective outcomes like how healthy hair looks. None of these are magic words, but their absence tells you how much of the result could be something else.

3. How many, and for how long

Small studies are not worthless, but they are fragile. Chance plays a larger role, one unusual participant moves the average, and harms that occur in one person per hundred will not appear in a study of twenty.

Duration matters especially in hair, because hair is slow. The growth cycle runs in months and years. A study measuring hair growth over four weeks is measuring noise, whatever it reports, because there was not time for the biology to do anything.

This is worth applying to findings you like as much as to ones you do not. The most-cited scalp massage study ran for 24 weeks, which is a reasonable duration, and had nine participants, which is not a reasonable number. Both facts are true at once.

4. What exactly was measured

Outcome switching is the most common way a weak study produces a strong claim.

Look for whether the measured outcome is the one you care about. Increased hair thickness is not increased hair count. Improved appearance of fullness is not regrowth. Reduced breakage in a combing test is not stronger hair. Each of those pairs sounds similar and means something different, and the marketing will reliably use the more impressive one.

Ask whether the outcome is objective or self-reported. Participants rating their own hair as improved is weak evidence, especially unblinded. A measured tensile strength or a photographic count assessed by someone who does not know the assignment is much stronger.

And look for an effect size, not just a p-value. Statistically significant means the result is unlikely to be chance. It says nothing about whether the size of the change is big enough for anyone to notice. A 2% improvement can be statistically significant and completely irrelevant to you.

5. Whose hair was it

This one is specific to this field and it matters more here than almost anywhere.

Cosmetic science built its reference data largely on straight hair. A finding from bleached Caucasian tresses may or may not transfer to type 4 coils, which differ in cross-sectional shape, curvature, lipid content and mechanical behaviour.

An audit of hair loss trials found demographic reporting to be incomplete, meaning the literature frequently does not record whose hair was studied. When it is recorded, textured hair is under-represented.

It is also worth saying that race and ethnicity are poor proxies for hair properties. What actually determines how a fibre behaves is curl pattern, diameter, density, and processing history. A study that reports ethnicity but not those things has not told you whether it applies to you.

Funding, honestly

Most cosmetic science is funded by industry. If you discard everything with a commercial interest behind it, you discard the field.

So sponsorship is not disqualifying. What it is, is a reason to look harder at the things sponsorship tends to affect: whether the comparator was chosen to be easy to beat, whether the outcome reported was the one originally planned, whether the data is available, and whether anyone independent has reproduced it.

A claim that survives more than one well-designed study, ideally including one the brand did not pay for, is in a different category from one resting on a single in-house result.

The short version

If a brand cannot tell you the answers, the honest interpretation is not that the product is useless. It is that clinically proven was a design choice rather than a finding.

When to see someone: A statistically positive trial is not automatically a clinically meaningful result. For persistent hair loss, scalp disease or adverse effects, use clinical advice rather than advertising claims as the decision point.

Evidence scope: These are general evidence-appraisal principles drawn from reporting standards for clinical trials, supplemented by an audit showing incomplete demographic reporting in hair-loss studies. They help you grade confidence in a claim; they cannot tell you whether a particular product will work on your hair.